- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01055470
Comparative Clinical Trial of Lornoxicam to Diclofenac in Patients of Osteoarthritis of Knee Joint.
January 22, 2010 updated by: Government Medical College, Bhavnagar
Open, Randomized, Controlled Clinical Trial of Lornoxicam as Compared to Diclofenac in Osteoarthritis of Knee Joint in Patients of Tertiary Care Hospital of Gujarat.
The purpose of this study was to compare the pain relieving action of the lornoxicam and diclofenac in patients of OA knee.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gujarat
-
Bhavnagar, Gujarat, India, 364001
- Sir Takthasinhji General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Newly diagnosed patient aged between 25 to 65 yrs of either gender suffering from osteoarthritis of knee according to criteria given by American College of Rheumatology
- Informed consent obtained from the patient.
Exclusion Criteria:
- Patients with any other systemic llness,
- Patients with pregnancy and lactation,
- Patients taking other drugs like lithium[4], digoxin, methotrexate, anticoagulants, antidiabetics, diuretics,
- Patients with H/O hypersensitivity to NSAIDs,
- Patients who had consumed any analgesics in last 1 month
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Diclofenac
Tab.Diclofenac 50 mg ,Orally, 12 hrly in morning and in evening after taking food for 3 months.
|
Tab. Diclofenac 50 mg 12 hrly, orally, in morning and in evening after taking food for 3 months.
|
Experimental: Lornoxicam
Tab. Lornoxicam 4 mg , orally, 8 hourly after taking food in morning , in noon and evening for 3 months.
|
Tab. Lornoxicam 4 mg , orally, 8 hourly after taking food in morning , in noon and evening for 3 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Difference in reduction in reading of Wong Baker face pain scale and in time of 100 meters walking test
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To monitor side effects of study drugs.
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Dr.Vishalkumar Kishorbhai Vadgama, M.B;B.S., Department of Pharmacology, Government Medical College, Bhavnagar-364001, Gujarat, India
- Study Chair: Dr. Chandrabhanu Rajkishore Tripathi, M.D. (Pharmacology), Proffessor and Head, Department of Pharmacology, Government Medical College, Bhavnagar-364001, Gujarat, India
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2008
Primary Completion (Actual)
June 1, 2009
Study Completion (Actual)
June 1, 2009
Study Registration Dates
First Submitted
January 22, 2010
First Submitted That Met QC Criteria
January 22, 2010
First Posted (Estimate)
January 25, 2010
Study Record Updates
Last Update Posted (Estimate)
January 25, 2010
Last Update Submitted That Met QC Criteria
January 22, 2010
Last Verified
January 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Arthritis
- Osteoarthritis
- Osteoarthritis, Knee
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Diclofenac
- Lornoxicam
Other Study ID Numbers
- Pharmacol no.02 /2008 Research
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis of Knee Joint
-
Stempeutics Research Pvt LtdStempeutics Research Malaysia SDN BHDCompleted
-
University Hospital, GhentCompletedOsteoarthritis of the Knee JointBelgium
-
zhoupingBeijing Friendship Hospital; Beijing Jishuitan HospitalUnknownOsteoarthritis Of KneeChina
-
Universidade Nova de LisboaHospital de Santa Maria, Portugal; NOVA Medical School; Hospital de Egas Moniz; Instituto de Medicina Molecular João Lobo Antunes and other collaboratorsUnknown
-
Ottawa Hospital Research InstituteCompleted
-
Aesculap AGRaylytic GmbHRecruitingKnee Osteoarthritis | Osteonecrosis | Knee Arthritis | Instability, Joint | Rheumatoid Arthritis of Knee | Deformity Knee | Primary Osteoarthritis of Knee Nos | Secondary Osteoarthritis of Knee NosAustralia, Germany
-
Hospices Civils de LyonSmith & Nephew, Inc.Completed
-
First Affiliated Hospital of Harbin Medical UniversityShanghai Baiying Medical Technology Co., Ltd.UnknownOsteoarthritis Of KneeChina
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
GCS Ramsay Santé pour l'Enseignement et la RechercheRecruitingUnilateral Primary Osteoarthritis of KneeFrance
Clinical Trials on Diclofenac
-
BDD Pharma LtdDrug Delivery International LtdCompleted
-
IBSA Institut Biochimique SARecruitingSoft Tissue InjuriesUnited States
-
MallinckrodtCompleted
-
Fidia Farmaceutici s.p.a.Completed
-
Hospital de Clinicas de Porto AlegreUnknown
-
Daré Bioscience, Inc.Active, not recruitingDysmenorrhea PrimaryAustralia
-
University of Maryland, BaltimoreFood and Drug Administration (FDA)Completed
-
FPR Specialty PharmacyUnknownKnee Injuries | Knee Pain ChronicUnited States
-
Javelin PharmaceuticalsCompleted